Atomic Bomb Irradiation-induced Leukemias Revisited : Summary Data of 50 Years-Long Term Follow Up Study on Survivors
スポンサーリンク
概要
- 論文の詳細を見る
Under the cooperation between Atomic Bomb Disease Institute (ABDI) of Nagasaki University School of Medicine, Institute of Nuclear Medicine of Hiroshima University and Radiation Effect Research Foundation (RERF), the Life Span Study (LSS) on 93,741 survivors (fixed cohort) and the Open City Study (OCS) on all survivors (unfixed) irrespective of whether they belonged to LSS or not, have been conducted in parallel over 45 years to ensure reliable case detection. For diagnosis and subtyping of detected leukemias, we adopted the FAB classifcation for acute leukemias and for exposure dose of individual survivors, the new dosimetry system 1986 (DS86). In LSS, 231 leukemia cases were analysed. There was strong evidence of radiation-induced risks for acute myeloid leukemia (AML), acute lymphoid leukemia (ALL) and chronic myeloid leukemia (CML), but not for adult T-cell leukemia (an endemic disease in Nagasaki area) and chronic lymphocytic leukemia. There was also significant difference between three major types with respect to the effects of age at bombing and sex, and in the temporal pattern of the elevated risks. For AML the dose response function was non-linear, whereas there was no evidence against linearity for ALL and CML. The hypothesis of a 0.5 Gy threshold could be rejected for three major types of leukemia. Excess Absolute Risk (EAR) estimates in cases per 10,000 Person Year Sievert (PYSv) were 0.6, 1.1, 0.9 for ALL, AML and CML, respectively. The corresponding relative risk at 1.0 Sv were 9.1, 3.3, 6.2, respectively. Although childhood exposure <15 age at bombing apparently induced three major types, the agerelated highest risk was observed for ALL. In OCS, 413 cases with DS86 estimates were used for analysis. Type specific incidence rates were calculated indirectly by using the over all incidence of leukemia from LSS data and multiplying these values by the corresponding proportions of cases in OCS. In conjunction with LSS data, the effects of radiation were significantly greater on the incidences of ALL and CML than on that of AML. In the high dose group there was a strong evidence for shorter incubation time and faster decline of elevated risk for ALL and CML than for AML. AML risk was apparently persistent through 1980. Thus, the differential effects of atomic bomb irradiation in inducing three major types of leukemia with respect of age-related and temporal patterns provide us insights into human leukemogenesis. Further investigation on radiation leukememogenesis undoubtedly requires molecular approach to detect type-specific genetic abnormlities including oncogenes and anti-oncogenes.
- 長崎大学の論文
著者
-
Tatsuki Matsuo
Division Of Blood Transfusion Nagasaki University School Of Medicine
-
Masao Tomonaga
Department Of Hematology Atomic Disease Institute
-
Tomonaga Masao
Department Of Haematology Atomic Bomb Disease Institute Nafasaki University School Of Medicine
-
Dale L.
Department Of Statistics Radiation Effect Research Foundation
-
Dale L.
Department Of Pediatrics Harbor General Hospital Ucla School Of Medicine
-
Matsuo Tatsuki
Division of Blood Transfusion, Nagasaki University School of Medicine
-
Preston Dalel.
Department of Statistics, Radiation Effect Research Foundation
関連論文
- In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Mental health conditions among atomic bomb survivors in Nagasaki
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Successful cord blood transplantation for mycosis fungoides.
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Human T cell leukemia virus type-1 Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-kB pathway
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological Diagnoses of the Japan Adult Leukemia Study Group Acute Myeloid Leukemia Protocols: Central Review
- Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody
- Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
- Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
- Consensus Conference on the Treatment of Aplastic Anemia
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Possible Involvement of Interferon Regulatory Factor 4 (IRF4) in a Clinical Subtype of Adult T-Cell Leukemia
- Recovery of Hematopoietic Progenitor Cells in Patients With Severe Aplastic Anemia Who Obtained Good Clinical Response With a Combination Therapy of Immunosuppressive Agents and Recombinant Human Granulocyte Colony-Stimulating Factor
- Kaposi's sarcoma - associated herpesvirus-like DNA sequences are not present in adult T-cell leukemia
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Possible Attenuation of Fas-Mediated Signaling by Dominant Expression of Caspase-8 Aberrant Isoform in Adult T-Cell Leukemia Cells
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Clinical and Oncologic Implications in Epigenetic Down-Regulation of CD26/Dipeptidyl Peptidase IV in Adult T-Cell Leukemia Cells
- Clinical Relevance of Survivin as a Biomarker in Neoplasms, Especially in Adult T-Cell Leukemias and Acute Leukemias
- Identification of Genes Associated with the Progression of Adult T Cell Leukemia (ATL)
- Real-Time Polymerase Chain Reaction for Quantification of HTLV-1 Proviral Load: Application for Analyzing Aberrant Integration of the Proviral DNA in Adult T-Cell Leukemia
- Atomic Bomb and Leukemia : II. BIOLOGICAL EFFECTS
- Cancer Mortality in Nagasaki Atomic Bomb Survivors with Epilation
- Correlation of donor-derived keratinocytes and severity of graft-versus-host disease (GVHD) in epidermis
- A case of primary pulmonary T cell lymphoma
- Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
- Membranous Nephropathy after Allogeneic Stem Cell Transplantation : Report of 2 Cases
- Atomic Bomb Irradiation-induced Leukemias Revisited : Summary Data of 50 Years-Long Term Follow Up Study on Survivors
- Myelodysplastic syndrome
- Late Medical Effects of Atomic Bombs Still Persisting after over Sixty Years
- A Trial of Vascular Regeneration by Autologous Bone Marrow Cells
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- THE RESPIRATORY DISTRESS SYNDROME : DIAGNOSIS AND TREATMENT
- A Case of .BETA.-thalassemia with a C.RAR.T Substitution at Position 654 of the Second Intervening Sequence of the .BETA.-globin Gene.